It’s good that oppies expire before results. So investors have to exercise before knowing the results so it beings in the cash irrespective of the results. As an investor I would have preferred to exercise oppies after results to minimise the risk however as the prophalyctic arm has already given positive results and the MC is quite low it just makes sense to exercise irrespective of the therapeutic arm results. (Btw I have exercised my oppies which are part of today’s Ann.)
I have high hopes for the therapeutic arm as someone who has undergone Dengue before. I am told that a second dengue attack is deemed really bad and could be fatal. So really hoping that we have a cure given the increased risk of mosquito borne diseases.
DYOR. No advice. Just a hopeful SH
- Forums
- ASX - By Stock
- ILA
- Ann: Completion of patient dosing in Phase 2b clinical trial
ILA
island pharmaceuticals limited
Add to My Watchlist
10.0%
!
13.5¢

Ann: Completion of patient dosing in Phase 2b clinical trial, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
13.5¢ |
Change
-0.015(10.0%) |
Mkt cap ! $31.87M |
Open | High | Low | Value | Volume |
15.0¢ | 15.0¢ | 13.0¢ | $52.62K | 392.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 461802 | 13.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 455032 | 0.130 |
2 | 120001 | 0.125 |
2 | 14644 | 0.120 |
3 | 80100 | 0.110 |
1 | 20000 | 0.105 |
Price($) | Vol. | No. |
---|---|---|
0.145 | 5000 | 1 |
0.150 | 27335 | 2 |
0.155 | 32405 | 3 |
0.160 | 119766 | 3 |
0.165 | 24864 | 1 |
Last trade - 15.48pm 27/06/2025 (20 minute delay) ? |
Featured News
ILA (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online